Assuming that insulin resistance and the obesity being the central pathogenic factor in the development of MS, a recent study reported the role of leptin, an adipokine associated with obesity, on the prediction of MS and CVD risk [29]. This evidence concerns the gene LEP and myeloid sarcoma.